The Chemours Company
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $670.0M | $713.0M | $1.20B | $1.10B | $1.45B | $1.11B | $943.0M | $1.20B |
| Accounts Receivable | $562.0M | $619.0M | $509.0M | $509.0M | $644.0M | $449.0M | $602.0M | $790.0M |
| Inventory | $1.57B | $1.46B | $1.35B | $1.40B | $1.10B | $939.0M | $1.08B | $1.15B |
| Total Current Assets | $3.00B | $3.02B | $3.84B | $3.21B | $3.35B | $2.63B | $2.78B | $3.29B |
| Property, Plant & Equipment | $3.08B | $3.19B | $3.21B | $3.17B | $3.15B | $3.47B | $3.56B | $3.29B |
| Goodwill | $46.0M | $46.0M | $102.0M | $102.0M | $102.0M | $153.0M | $153.0M | — |
| Intangible Assets (Excl. Goodwill) | $2.0M | $3.0M | $3.0M | $13.0M | $6.0M | $14.0M | $21.0M | $28.0M |
| Total Assets | $7.38B | $7.51B | $8.24B | $7.64B | $7.55B | $7.08B | $7.26B | $7.36B |
| Liabilities | ||||||||
| Accounts Payable | $954.0M | $1.16B | $1.16B | $1.23B | $1.16B | $844.0M | $923.0M | $1.14B |
| Total Current Liabilities | $1.69B | $1.82B | $2.49B | $1.89B | $1.86B | $1.44B | $1.54B | $1.71B |
| Long-Term Debt | $4.10B | $4.06B | $3.99B | $3.59B | $3.72B | $4.01B | $4.03B | $3.96B |
| Total Liabilities | $7.13B | $6.94B | $7.52B | $6.53B | $6.47B | $6.27B | $6.56B | $6.34B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $1.22B | $1.69B | $1.78B | $2.17B | $1.75B | $1.30B | $1.25B | $1.47B |
| Total Stockholders' Equity | $250.0M | $571.0M | $721.0M | $1.11B | $1.08B | $813.0M | $689.0M | $1.01B |